Leaders with Broad Strategic Vision
We are focused on making the currently complex world of vendor selection much easier for the BioPharma Manufacturer. Our goal is to enhance the vendor experience by ensuring that the best vendors are identified and ultimately selected. Our Vendor Analysis Tool aggregated the responses of over 200 BioPharma decision makers and rates individual vendors on a capability by capability perspective.
The Vendor Analysis Tool is 100% populated with key decision maker and budget holder feedback. With the Vendor Analysis Tool, you can easily and strategically orchestrate Request for Proposals and Request for Information from the highest rated vendors servicing the BioPharma Industry. Selecting the right vendor leads to increased productivity, higher levels of innovation and greater internal client satisfaction.
Bob Jansen – CEO
Bob Jansen is a veteran of the Pharmaceutical and Life Science community. Bob spent over 19 years in various leadership roles at different Pharmaceutical manufacturers before transitioning to the vendor side of the business. Most recently, Bob was President and General Manager of Source Healthcare Analytics, a Symphony Technology Company (formerly Wolters Kluwer). Bob founded Zensights in Dec. of 2012 to provide insights to Lifescience companies and those suppliers that service the industry.
Bob collaborates with a vast network of Life science executives and key opinion leaders to help clients determine “Best in Class” vendors on a capability by capability perspective. These “Zensights” help BioPharma manufacturer’s determine which vendors have a “Best in Class” offering on a capability by capability perspective. Bob uses industry surveys of Pharmaceutical budget holders to determine vendor performance.
These insights often help suppliers determine shortcomings or opportunities to augment their product offerings to help their end customers. (Life science/Pharma manufacturer’s) Zensights focuses on providing insights on vendors whose key differentiator tends to be their employees.
Connect with Bob on Linkedin
Will Passano – President
Will Passano has extensive executive healthcare leadership expertise in the healthcare publishing / education sectors. With a foundation acquired from traditional publishing offerings that includes Williams & Wilkins, SCP Communications, and Jobson Healthcare Information, to more digital offerings like Skyscape, NetLearning and VOX Telehealth, he has been instrumental in growing these entities.
His strong and seasoned management skill set has provided guidance as several of these organizations were successfully sold during his leadership and he has a strong background in sales, internal operations, partner/lender and investor relations, With the rapidly changing landscape within the healthcare sector, he has successfully adapted to capitalize on this dynamic shift.
Connect with Will on Linkedin
Lieutenant General (Ret.) Rick Lynch
With over 34 years in the US Army at his heel, Lieutenant General (Ret.) Rick Lynch has distinguished himself as an exceptional leader and strategist through his chameleon-like ability to adapt to change despite the most challenging obstacles. From surmounting his parents’ inability to pay for college by gaining entry to West Point to leading “The Surge” in Iraq as Army General with only six weeks to prepare, Lieutenant General Lynch has constructed a disciplined and effective mantra for success, which he shares with audiences across the country today.
From company (about 100 soldiers) to corps (about 65,000 soldiers) to the head of all US Army installations, Lynch steadily climbed his way up, eventually commanding at all levels. Matching the professional acumen of established business leaders, he was responsible for managing all the installations in the US Army with an annual budget of $12 billion and a workforce of 120,000. Combining this impeccable work ethic with an open heart, he also effectively lowered divorce and suicide rates at Fort Hood, Texas, by outlawing weekend work and mandating soldier family time.
Lynch’s book, Adapt or Die: Battle Tested Principles for Leaders, provides unprecedented clarity to leaders from all walks of life. In it, he offers insight born from overcoming adversity on both the battlefield and in the boardroom. With refreshing directness, he shares how to gain the confidence needed to lead in our ever-changing world. His new book, Work Hard Pray Hard: The Power of Faith in Action will be released in April 2017.
In his commanding presentations, Lynch captivates audiences with the tenor of his voice and the approachable, conversational nature of his tone. Drawing on his personal experience in and out of combat, he powerfully illustrates his principles, from the foundation of business leadership to the need for resiliency and engagement.
Connect with Rick on Linkedin
Sharon Clarke is an accomplished pharmaceutical industry executive with more than 20 years of senior leadership experience including the role of President and General Manager of Meda Pharmaceuticals. Sharon has vast experience in commercial operations roles for several midsize and small pharmaceutical companies.
After spending three years leading Meda Pharmaceuticals, Sharon founded Patriot Advisors, a business consulting firm, and also served as Vice President of Global Initiatives at The Xtra Mile Group. She counseled both emerging biotechnology companies and established global pharmaceutical companies seeking to optimize organizational effectiveness and manage change.
Currently Sharon serves as the Chief Business Officer for JDP Therapeutics, a privately held, clinical Phase 3 stage specialty pharmaceutical company focused on developing small molecule therapeutics to treat life-threatening diseases. She is Chief Commercial Officer at Tris Pharma a privately held pharmaceutical company based in Monmouth Junction, NJ.
Sharon graduated magna cum laude from East Tennessee State University with degrees in Microbiology and Chemistry and is a member of the University Board of Trustees. Sharon serves on the Human Resources Committee for Notre Dame High School in Lawrenceville, NJ and lives in Robbinsville with her husband and 3 children.
Connect with Sharon on Linkedin
Matt Brown is an accomplished agency leader and brand strategist, having spent the past two decades successfully building and launching dozens of healthcare brands for clients such as Genentech, Gilead, Johnson & Johnson, Merck and Zoetis. In addition to creating great brands for clients, Matt has spent the past 10 years building some of the industry’s leading agency brands. Most recently, Matt launched BrandMETTLE, an agency focused on bringing branding expertise and innovative technologies to brands engaging the 50+ consumer. Previously, Matt successfully created Guidemark Health by merging 5 independent healthcare agencies. While CEO of Guidemark Health, Matt served as interim CEO of Bluespire Marketing and Ariad Communications for about a year, which were both owned by the same private equity group as Guidemark Health.
Before Guidemark Health, Matt served as general manager of ICC Lowe. In addition to guiding the organizations transformation, Matt oversaw client relationships, new business activities, and worked closely with clients on the marketing of their products. Prior to ICC Lowe, Matt served as president of Ignite Health. During his tenure, the agency was nominated for Agency of the Year in recognition of significant growth and expansion. Matt served as senior vice president/managing director for GSW Worldwide prior to joining Ignite Health. During his 10 years at GSW, he held several positions with responsibility for leading account services, new business, staff development, as well as innovative business models and communications solutions for clients.
Matt is a graduate of The Ohio State University and served in the Army National Guard for 6 years before starting his professional career. Matt lives in Long Valley, New Jersey with his wife and 3 children.
Connect with Matt on Linkedin
Martin Layding has 20 years progressive Financial experience across multiple industries and corporate financial disciplines. Marty’s focus has been on building strong relationship with multifunctional partners to drive shareholder value through topline and margin enhancing initiatives.
Currently CFO of Coach, Inc.’s International Business Group; his previous experiences include financial leadership roles in Supply Chain, FP&A and Strategy teams for Procter & Gamble, Novartis Consumer Health, Coach, Inc. and Wolters Kluwer Health.
Connect with Marty on Linkedin
Al Reicheg has spent 25+ years in the healthcare industry. The first 15+ years were spent on the commercial side of life sciences. He held positions of increasing responsibility including sales, sales training, sales management, marketing, managed markets, and business development for a number of pharma companies.
After catching the entrepreneurial bug, Al spent the past 10 years building and executing a commercialization strategy for an entrepreneurial data analytics and predictive modeling company. Through the years, he has had the opportunity to evaluate the strengths and weaknesses of hundreds of healthcare service companies – from both the corporate and service provider perspectives. After leading the process of identifying a buyer and negotiating a sale of his previous company, to a healthcare private equity firm, Al launched Sea Change Healthcare Consulting. Al’s deep commercial insights, market savvy, and unwavering commitment to integrity have helped him build a broad C Suite network. A strong believer in karma; if he can’t help you solve a problem, Al probably knows someone who can and is happy to make the connection.
About Sea Change Healthcare Consulting
Sea Change is Al’s latest venture and is exclusively focused on providing strategic advisory services to health care service companies. Areas of expertise include commercialization, sales & marketing strategic/tactical planning, business development, corporate development, managing accelerated growth, and M&A strategy. Sea Change works closely with clients to identify objectives, accelerate transformation, and help companies achieve their goals…faster!
Connect with Al on Linkedin
Lou Sanquini has more than 20 years of experience in the pharmaceuticals industry. Following sixteen years with GSK in sales, managed care and marketing, he moved to Meda where responsibilities included leadership roles in consumer, physician and portfolio marketing. Overall, he launched eleven brands, including a number of novel brands, “me too,” and loss of exclusivity follow-on brands.
He joined QualityHealth, a pharmaceutical marketing services company, to assist in the pivot from plateau to growth. Subsequent to the introduction two new verticals and a number of products, conceived to effectively meet the industry’s unmet needs, the company grew sales by 30%. His efforts significantly contributed to the sale of QualityHealth to Sharecare.
Currently, Lou is EVP of Marketing & BD at Sharecare and holds a Board Position with the New York City Health Business Leaders in addition to the Advisory Board Position with Zensights. Additionally, he is a member of the St. Peter’s Church Council where he heads-up community and fund raising efforts for the 225 year old institution.
Lou graduated with a B.S. from West Chester University of Pennsylvania. He lives in NYC with his wife and two daughters.
Connect with Lou on Linkedin
Brian J. Smith
Brian J. Smith graduated from Loras College in 1977 – B.A. in Business Administration. He went on to obtain an M.B.A. from Dominican University in 1984 and is an Alumnus of The Harvard Business School, having completed the OPM Program in 2006.
Brian began his career in the health care industry as a sales representative for Johnson and Johnson’s Ethicon Division. He joined Boehringer Ingleheim as a hospital sales representative in Chicago where he later relocated to the company’s home office in Ridgefield, Connecticut to take on various cardiovascular marketing positions.
In 1986, Brian joined Lederle Labs’ International Division where he headed up the company’s marketing initiative to launch new cardiovascular products in Europe and the Far East. He went on to hold senior marketing and sales positions at Forest Laboratories, Watson Pharmaceuticals and Boron LePore & Associates. He was a Division President -Corporate Officer of Boron LePore during the IPO in 1998.
Brian has served as CEO and Co-founder of Argent Development Group since 2004. Brian was Co-founder of Manchester Pharmaceuticals which was sold to Retrophin in 2014. Presently, he serves as Co-founder and COO of Melbourne Laboratories, and Co- founder and President of Valcrest Pharmaceuticals.
In addition to Argent, Brian is on the Board of Directors of several privately held pharmaceutical, drug development and health care companies. In 2015, he joined the Board of Directors of DermAvance Pharmaceuticals.
Brian is a member of the Board of Regents for Loras College and is a member of The Executive Committee. Brian is on the Board of Trustees for Cristo Rey High School in Brooklyn New York.
Connect with Brian on Linkedin